Biotricity, Inc. is a medical technology company, which engages in biometric data monitoring solutions. The company is headquartered in Redwood City, California and currently employs 46 full-time employees. The company went IPO on 2015-10-26. The firm developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patient’s electrocardiogram (ECG) data for monitoring and diagnostic purposes. Its Bioflux platform has a built-in cellular chipset and a real-time embedded operating system, which allows for its technology to be utilized as an Internet of Things (IoT) platform. The company has developed several technologies, including Biotres, Bioheart, and Biocare. Biotres is an ECG Holter solution that addresses the limitations of existing solutions in the Holter market. Bioheart is a personal cardiac monitoring solution for consumers. Biocare is a cardiac disease management platform for chronic care management and remote patient monitoring.
Follow-Up Questions
Qui est le CEO de Biotricity Inc ?
Mr. Waqaas Al-Siddiq est le Chairman of the Board de Biotricity Inc, il a rejoint l'entreprise depuis 2016.
Quelle est la performance du prix de l'action BTCY ?
Le prix actuel de BTCY est de $0.64, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Biotricity Inc ?
Biotricity Inc appartient à l'industrie Health Care et le secteur est Health Care
Quelle est la capitalisation boursière de Biotricity Inc ?
La capitalisation boursière actuelle de Biotricity Inc est de $17.1M
Est-ce que Biotricity Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 3 analystes ont établi des notations d'analystes pour Biotricity Inc, y compris 0 achat fort, 0 achat, 3 maintien, 1 vente et 0 vente forte
